Grant M Fischer
Overview
Explore the profile of Grant M Fischer including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
19
Citations
682
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Guerrieri R, Fischer G, Kircher D, Joon A, Cortez J, Grossman A, et al.
bioRxiv
. 2025 Feb;
PMID: 39896644
Structured Abstract: Melanoma mortality is driven by the formation and growth of distant metastases. However, the process and pathogenesis of melanoma metastasis remain poorly understood. Here, we interrogate the role...
2.
Fischer G, Lamba N, Vogelzang J, Aizer A, Ligon K
Clin Cancer Res
. 2025 Jan;
31(4):719-732.
PMID: 39786469
Purpose: Melanoma brain metastases (MBM) are a common and lethal complication of metastatic melanoma. Despite improvements in treatments, subsets of patients with MBM experience rapid clinical decline, and currently, few...
3.
Mahajan A, Chen R, Fischer G, Xiong Y, Ashrafzadeh S, Said J, et al.
JAAD Case Rep
. 2024 Dec;
54:69-72.
PMID: 39654850
No abstract available.
4.
Fischer G, Mahadevan N, Hornick J, Fletcher C, Russell-Goldman E
Mod Pathol
. 2024 Sep;
37(12):100626.
PMID: 39332711
Undifferentiated melanoma, defined as melanoma that has lost all usual phenotypic and immunohistochemical characteristics of conventional melanoma, can pose significant diagnostic challenges. Molecular studies have advanced our understanding of undifferentiated...
5.
Glitza Oliva I, Ferguson S, Bassett Jr R, Foster A, John I, Hennegan T, et al.
Nat Med
. 2024 Apr;
30(6):1787.
PMID: 38649781
No abstract available.
6.
Fischer G, Papke Jr D
Semin Diagn Pathol
. 2023 May;
40(4):246-257.
PMID: 37156707
Cutaneous mesenchymal neoplasms are diagnostically challenging because of their overlapping morphology, and, often, the limited tissue in skin biopsy specimens. Molecular and cytogenetic techniques have identified characteristic gene fusions in...
7.
Fischer G, Gliem T, Greipp P, Rosenberg A, Folpe A, Hornick J
Mod Pathol
. 2023 Apr;
36(8):100191.
PMID: 37080393
Kaposi sarcoma (KS) is a human herpesvirus 8 (HHV8)-associated vascular proliferation that most often involves the skin. Rarely, KS shows marked nuclear atypia or pleomorphism; such examples are known as...
8.
Glitza Oliva I, Ferguson S, Bassett Jr R, Foster A, John I, Hennegan T, et al.
Nat Med
. 2023 Mar;
29(4):898-905.
PMID: 36997799
There is a critical need for effective treatments for leptomeningeal disease (LMD). Here, we report the interim analysis results of an ongoing single-arm, first-in-human phase 1/1b study of concurrent intrathecal...
9.
Fischer G, Lindeman N, Ligon A, Russell-Goldman E
Am J Dermatopathol
. 2022 Nov;
45(4):217-226.
PMID: 36346171
Proliferating pilar tumors (PPTs) are rare neoplasms of external root sheath derivation, which most commonly occur on the scalp of elderly women. Although typically showing classic histologic features such as...
10.
Hahn A, Menk A, Rivadeneira D, Augustin R, Xu M, Li J, et al.
Clin Cancer Res
. 2022 Sep;
29(1):154-164.
PMID: 36166093
Purpose: Overweight/obese (OW/OB) patients with metastatic melanoma unexpectedly have improved outcomes with immune checkpoint inhibitors (ICI) and BRAF-targeted therapies. The mechanism(s) underlying this association remain unclear, thus we assessed the...